Going Vegan With RA
|
|
By Johns Hopkins Health Alerts; www.johnshopkinshealthalerts.com
People with rheumatoid arthritis (RA) often turn to therapies that are outside the medical mainstream, especially when conventional medications are not working or are causing troubling side effects. Now a study reported in Arthritis & Rheumatism (Volume 59, page 186) suggests that following a gluten-free vegan diet may protect rheumatoid arthritis (RA) patients from heart disease and stroke. Here’s what the research suggests. More...
Posted in Arthritis on February 1, 2010
|
|
Read Alert | Read Comments
|
|
View more Arthritis Health Alerts
|
Colon Cancer Surgery: Open or Laparoscopic?
|
|
By Johns Hopkins Health Alerts, www.johnshopkinshealthalerts.com
Colon cancer operations are low risk, and in recent years major surgical advances, like the increasing use of minimally invasive laparoscopic techniques, have been helping patients live longer with fewer side effects. In this excerpt of an article from our Health After 50 newsletter, Michael A. Choti, M.D., the Jacob C. Handelsman Professor of Surgery at Johns Hopkins and Director of the Johns Hopkins Colon Cancer Center talks about colon cancer surgery. More...
Posted in Colon Cancer on February 2, 2010
|
|
Read Alert | Read Comments
|
|
View more Colon Cancer Health Alerts
|
Do You Need a PAD?
|
|
By Johns Hopkins Health Alerts; www.johnshopkinshealthalerts.com
In many health emergencies, such as heart attacks and strokes, doctors make all the decisions. The same is often true of mental health crises as well. But if you have a psychiatric condition that could lead to hospitalization -- such as bipolar disorder, schizophrenia, or severe depression -- you may have strong feelings about various treatment options. This is when a psychiatric advance directive (PAD) can be just what the patient ordered. More...
Posted in Depression and Anxiety on February 3, 2010
|
|
Read Alert | Read Comments
|
|
View more Depression and Anxiety Health Alerts
|
Pros and Cons of Daily Medication for GERD
|
|
By Johns Hopkins Health Alerts; www.johnshopkinshealthalerts.com
Gastroesophageal reflux disease (GERD) is a chronic condition, which means that it requires a long-term strategy. For many people, the recommended treatment for frequent heartburn is taking a daily medication indefinitely, a regimen known as continuous maintenance therapy. The goal is to prevent a relapse of GERD symptoms. It is a good idea to stop taking your acid blocker when you don’t have symptoms? Here’s advice from Johns Hopkins. More...
Posted in Digestive Health on February 8, 2010
|
|
Read Alert | Read Comments
|
|
View more Digestive Health Alerts
|
What Is Non-HDL Cholesterol?
|
|
By Johns Hopkins Health Alerts; www.johnshopkinshealthalerts.com
Although levels of LDL ('bad') cholesterol are the primary focus of a cholesterol screening (which also measures total cholesterol, HDL ['good'] cholesterol, and triglycerides), about half of all heart attacks occur in people with normal LDL levels. So researchers have looked at other measurements that can help identify people at risk for cardiovascular disease. More...
Posted in Heart Health on January 22, 2010
|
|
Read Alert | Read Comments
|
|
View more Heart Health Alerts
|
The Mental Health Consequences of COPD
|
|
By Johns Hopkins Health Alerts; www.johnshopkinshealthalerts.com
When you hear that you have a serious medical condition like chronic obstructive pulmonary disease (COPD), it's normal to feel anxious and worried about the future. And with the increasing limitations on daily activities that often accompany the condition, it's not surprising that you're likely to feel sad. But if these feelings last for more than a few weeks and interfere with your daily life, you could have an anxiety disorder or depression. More...
Posted in Lung Disorders on January 21, 2010
|
|
Read Alert | Read Comments
|
|
View more Lung Disorders Health Alerts
|
Update on The Search for an Alzheimer's Cure
|
|
By Johns Hopkins Health Alerts; www.johnshopkinshealthalerts.com
Alzheimer' s drugs currently on the market can slow the disease, but there is still no cure. Nearly all major pharmaceutical companies in the United States are racing to find one, but since the cause of Alzheimer's is still a mystery, scientists aren't sure where in the brain to aim treatment. In this excerpt from an article in our Health After 50 newsletter, Johns Hopkins discusses therapies in the pipeline that attack amyloid plaques as a way to stall Alzheimer's. More...
Posted in Memory on January 25, 2010
|
|
Read Alert | Read Comments
|
|
View more Memory Health Alerts
|
|
